<乌鸦传媒>CPAP Turns in Mixed Results for Patients With Diabetic Eye Disease Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
<乌鸦传媒>Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
<乌鸦传媒>Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetes The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
<乌鸦传媒>Hybrid Closed-Loop Insulin System for T1D Safe, Effective During Pregnancy However, no FDA-approved systems have a pregnancy indication yet Oct 05, 2023
<乌鸦传媒>Mixed Bag for Early Metformin in Gestational Diabetes EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
<乌鸦传媒>Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
<乌鸦传媒>FDA Adds Intestinal Blockage Reports to Ozempic Labeling Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
<乌鸦传媒>Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugs Lower risk compared with DPP-4 inhibitors, and聽similar risk versus GLP-1 receptor agonists Sep 26, 2023
<乌鸦传媒>FDA Approves Another SGLT2 Inhibitor for Treating CKD Empagliflozin adds indication in adults, regardless of diabetes status Sep 22, 2023
<乌鸦传媒>FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetes We haven't seen "the best version of this device," said panel member Sep 22, 2023
<乌鸦传媒>Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise. Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
<乌鸦传媒>Direct-to-Consumer Lab Tests Raise Ethical Questions, Researchers Say Privacy policies, terms of sale often are unclear Sep 18, 2023
<乌鸦传媒>Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
<乌鸦传媒>Mask Attack Leaves Actor Blind; Diabetes Risk in Night Owls; U.S. Blood Shortage Health news and commentary from around the Web gathered by 乌鸦传媒 staff Sep 12, 2023
<乌鸦传媒>When Temps Rise, So Do Medical Risks. Should Docs and Nurses Talk More About Heat? "This is not your grandmother's heat," says policy expert Sep 10, 2023
<乌鸦传媒>New Weight-Loss Drugs Spark Debate About Safety During Surgery Some anesthesiologists think current guidelines don't go far enough Sep 08, 2023
<乌鸦传媒>Low-Dose Semaglutide Can Ease Insulin Need in Early T1D, Small Series Shows All 10 patients were able to eliminate prandial insulin use within 3 months Sep 06, 2023
<乌鸦传媒>Case Grows for SGLT2 Inhibitors as Gout Treatment Large cohort study shows expansive benefits Aug 28, 2023
<乌鸦传媒>SGLT2 Inhibitors, Rapid Titration, IV Iron Get a Boost in New European HF Guideline Other recommendations also released for endocarditis, cardiomyopathies, ACS, and more Aug 25, 2023
<乌鸦传媒>Should People Without Diabetes Use Glucose Monitors? Trend boosted by health buffs on social media, but benefit for healthy adults is unclear Aug 01, 2023
<乌鸦传媒>Kombucha Shows Potential Diabetes Benefit in Small Trial Diabetes patients saw glucose levels drop after drinking fermented tea Aug 01, 2023
<乌鸦传媒>Albuminuria Testing Falling Short in Patients at Risk for CKD If testing rates followed recommendations, some could start necessary meds sooner Jul 27, 2023
<乌鸦传媒>Aspartame Is a 'Possible' Carcinogen, WHO Declares But the organization's recommended limits on aspartame consumption remain unchanged Jul 13, 2023
<乌鸦传媒>Diabetes Projected to Affect 1.3 Billion People by 2050 Advance of disease driven by high BMI, with social determinants of health playing a role Jun 28, 2023
<乌鸦传媒>Protocol Optimizing Meds for T2D and CVD Pushed Beyond Cardiology Alone Endocrinologists urged to pay attention to COORDINATE trial Jun 27, 2023
<乌鸦传媒>Semaglutide Plus Cagrilintide Reduced Blood Sugar, Weight in T2D Once-weekly CagriSema reduced body weight more than either agent alone Jun 27, 2023
<乌鸦传媒>High-Dose Semaglutide Pill Just as Effective as Wegovy for Weight Loss Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose Jun 27, 2023
<乌鸦传媒>Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trial Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease Jun 26, 2023
<乌鸦传媒>Bempedoic Acid Gets 'Huge' Win for Primary Prevention in the Statin-Intolerant More positive results in CLEAR Outcomes sub-analysis Jun 26, 2023
<乌鸦传媒>Once-Weekly Insulin Icodec Bests Daily Insulin Options for Type 2 Diabetes Superior to once-a-day insulin glargine U100 and degludec Jun 25, 2023
<乌鸦传媒>Near 15% Weight Loss With Novel Oral GLP-1 RA in Phase II Obesity Trial Daily orforglipron also lowered HbA1c in type 2 diabetes Jun 24, 2023
<乌鸦传媒>Novel Agent Leads to Fibrosis Improvement in NASH Phase IIb ENLIVEN trial saw success with various doses of pegozafermin Jun 24, 2023
<乌鸦传媒>Expunge Nazi-Era Medical Terms? Off-Brand Wegovy Clinics Sued; Copy and Paste Bloat Health news and commentary from around the Web gathered by 乌鸦传媒 staff Jun 21, 2023
<乌鸦传媒>Wide Variation in CGM Settings for Kids With Diabetes Signals Education Gaps Researcher warns of "alarm fatigue" if thresholds aren't optimized to patient Jun 20, 2023
<乌鸦传媒>More Evidence Backs Gout Benefit for Gliflozin Agents New study finds marked risk reduction tied to drugs' urate-lowering effect Jun 02, 2023
<乌鸦传媒>FDA Warns on Certain Forms of Compounded Semaglutide Some products may not contain the same active ingredient as the approved drugs Jun 01, 2023
<乌鸦传媒>Sotagliflozin Gets FDA's Blessing for Heart Failure SGLT1/SGLT2 inhibitor approved on the basis of SOLOIST-WHF, SCORED trials May 27, 2023
<乌鸦传媒>Topical Esmolol Gel Helped Heal Diabetic Foot Ulcers Significantly better than standard of care at 12 and 24 weeks May 15, 2023
<乌鸦传媒>Senators Call Out PBMs, Drugmakers for High Prescription Drug Costs This "is a moral issue," Sen. Bernie Sanders said during the hearing May 11, 2023
<乌鸦传媒>Adding This New Criteria Drastically Cut 72-Hour Insulinoma Fast Time Beta-hydroxybutyrate-based stopping point reduced burden on patients May 08, 2023
